Shu-Chih Chen
Founder at ATOSSA THERAPEUTICS, INC.
Net worth: - $ as of 2024-06-29
Shu-Chih Chen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Director/Board Member | 2009-03-31 | - |
| Founder | 2008-11-30 | - | |
| Chief Tech/Sci/R&D Officer | 2010-03-31 | - |
Career history of Shu-Chih Chen
Former positions of Shu-Chih Chen
| Companies | Position | Start | End |
|---|---|---|---|
| SC2Q Consulting Co. | Founder | 2005-12-31 | 2007-12-31 |
| President | - | 2007-12-31 | |
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Director/Board Member | 2001-12-31 | 2005-12-31 |
| Ensisheim Partners LLC | President | 2007-12-31 | - |
| National Yang Ming University | Corporate Officer/Principal | - | - |
Training of Shu-Chih Chen
| Michigan State University | Doctorate Degree |
| National Yang Ming University | Undergraduate Degree |
Statistics
International
| United States | 6 |
| Taiwan | 2 |
Operational
| Director/Board Member | 2 |
| Founder | 2 |
| President | 2 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| SC2Q Consulting Co. | |
| Ensisheim Partners LLC | |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
- Stock Market
- Insiders
- Shu-Chih Chen
- Experience
